Matthew Tindall

Mr. Tindall has extensive entrepreneurial management experience as a CEO/Executive/Co-Founder of healthcare companies in the rare disease, oncology, pain, cardiovascular and genomics spaces with Fabric Genomics, Kodikaz, Wheatsheaf Group, IQVIA, Digitas Health, Genzyme Corporation, Celera Genomics, Eli Lilly & Company and Sarentis Therapeutics.